EyeCool Therapeutics

Cambridge, MA · Founded 2021 · Privately Held (backing)

Developer of a novel device-based technology designed to focus on developing innovative treatments for Chronic Ocular Surface Pain (COSP). EyeCool Therapeutics is based in Cambridge, MA and was founded in 2021. It has raised $12.5 million.

Last price · $/share

—

Implied valuation

—

Total raised

$12.5M

Last round

—

How much has EyeCool Therapeutics raised?

$12.5Macross 0 recorded rounds

Free account

More of EyeCool Therapeutics with a free account

·Watch EyeCool Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

EyeCool Therapeutics investors

6 investors are on record for EyeCool Therapeutics, including PV Capital Management, Angel Physicians Fund, Catalyst Health Ventures and Excelestar Ventures.

For fundraisers

Raising for a company like EyeCool Therapeutics?

6 investors have backed EyeCool Therapeutics.

See all 6 investors →

Frequently asked about EyeCool Therapeutics

How much has EyeCool Therapeutics raised?: EyeCool Therapeutics has raised $12.5M in total across 0 recorded funding rounds.